Triptorelin, a decapeptide and synthetic analogue of gonadotropin-releasing hormone (GnRH), plays a crucial role in regulating sex hormone release. Widely used in medicine, it has shown therapeutic efficacy in hormone-responsive cancers like prostate and breast cancer, endometriosis, and precocious puberty.
Triptorelin acts by binding to GnRH receptors on the anterior pituitary gland. Initially, it stimulates luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release. However, according to research, prolonged administration leads to receptor desensitization and downregulation, causing reduced secretion of LH and FSH. This results in a chemical castration state, which aids in managing hormone-dependent conditions.
Showing all 3 results
[1] https://pubmed.ncbi.nlm.nih.gov/15082521/
[2] https://pubmed.ncbi.nlm.nih.gov/21788033/
[3] https://pubmed.ncbi.nlm.nih.gov/11978277/
[4] https://pubmed.ncbi.nlm.nih.gov/19332438/
[5] https://pubmed.ncbi.nlm.nih.gov/11208825/
[6] https://pubmed.ncbi.nlm.nih.gov/22733160/
DISCLAIMER: We do not supply peptides to any individual under the age of 21. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY in the process of laboratory research by responsible trained and professional individuals. All products listed on this website (https://united-kingdom.direct-peptides.com) and provided through Direct Peptides are intended for laboratory research purposes only. The products listed on this website are NOT for human or animal consumption or ingestion of any kind.
401 N. Mills Ave, Ste B, Orlando, FL 32803, United States